94 related articles for article (PubMed ID: 30609035)
1. Low expression of CRISP3 predicts a favorable prognosis in patients with mammary carcinoma.
Wang Y; Sheng N; Xie Y; Chen S; Lu J; Zhang Z; Shan Q; Wu D; Zheng G; Li M; Zheng Y; Fan S
J Cell Physiol; 2019 Aug; 234(8):13629-13638. PubMed ID: 30609035
[TBL] [Abstract][Full Text] [Related]
2. CRISP3 expression drives prostate cancer invasion and progression.
Volpert M; Furic L; Hu J; O'Connor AE; Rebello RJ; Keerthikumar S; Evans J; Merriner DJ; Pedersen J; Risbridger GP; McIntyre P; O'Bryan MK
Endocr Relat Cancer; 2020 Jul; 27(7):415-430. PubMed ID: 32357309
[TBL] [Abstract][Full Text] [Related]
3. Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.
Dahlman A; Edsjö A; Halldén C; Persson JL; Fine SW; Lilja H; Gerald W; Bjartell A
Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):369-75. PubMed ID: 20680031
[TBL] [Abstract][Full Text] [Related]
4. MiR-182-5p, MiR-192-5p, and MiR-493-5p Constitute a Regulatory Network with CRISP3 in Seminal Plasma Fluid of Teratozoospermia Patients.
Gholami D; Amirmahani F; Yazdi RS; Hasheminia T; Teimori H
Reprod Sci; 2021 Jul; 28(7):2060-2069. PubMed ID: 33620707
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor mediated epigenetic regulation of CRISP3 promoter in prostate cancer cells.
Pathak BR; Breed AA; Deshmukh P; Mahale SD
J Steroid Biochem Mol Biol; 2018 Jul; 181():20-27. PubMed ID: 29477539
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis.
Dahlman A; Rexhepaj E; Brennan DJ; Gallagher WM; Gaber A; Lindgren A; Jirström K; Bjartell A
Mod Pathol; 2011 May; 24(5):708-19. PubMed ID: 21240253
[TBL] [Abstract][Full Text] [Related]
7. The expression of β-microseminoprotein but not CRISP3 is reduced in ovarian cancer and correlates to survival.
Henriksen R; Lundwall Å; Udby L; Fernlund P
Anticancer Res; 2012 Sep; 32(9):3993-9. PubMed ID: 22993349
[TBL] [Abstract][Full Text] [Related]
8. Endometrial CRISP3 is regulated throughout the mouse estrous and human menstrual cycle and facilitates adhesion and proliferation of endometrial epithelial cells.
Evans J; D'Sylva R; Volpert M; Jamsai D; Merriner DJ; Nie G; Salamonsen LA; O'Bryan MK
Biol Reprod; 2015 Apr; 92(4):99. PubMed ID: 25715794
[TBL] [Abstract][Full Text] [Related]
9. Cysteine-rich secretory protein 3 inhibits hepatitis C virus at the initial phase of infection.
Lee U; Nam YR; Ye JS; Lee KJ; Kim N; Joo CH
Biochem Biophys Res Commun; 2014 Jul; 450(2):1076-82. PubMed ID: 24978310
[TBL] [Abstract][Full Text] [Related]
10. Equine CRISP3 modulates interaction between spermatozoa and polymorphonuclear neutrophils.
Doty A; Buhi WC; Benson S; Scoggin KE; Pozor M; Macpherson M; Mutz M; Troedsson MH
Biol Reprod; 2011 Jul; 85(1):157-64. PubMed ID: 21389342
[TBL] [Abstract][Full Text] [Related]
11. Identification of CRISP2 from human sperm as PSP94-binding protein and generation of CRISP2-specific anti-peptide antibodies.
Anklesaria JH; Kulkarni BJ; Pathak BR; Mahale SD
J Pept Sci; 2016 Jun; 22(6):383-90. PubMed ID: 27161017
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition properties of the putative prostate cancer biomarkers PSP94 and CRISP-3.
Van Eynde A; Litovkin K; Bollen M
Asian J Androl; 2011 Mar; 13(2):205-6. PubMed ID: 21102472
[No Abstract] [Full Text] [Related]
13. Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling.
He LF; Xu HW; Chen M; Xian ZR; Wen XF; Chen MN; Du CW; Huang WH; Wu JD; Zhang GJ
Oncotarget; 2017 Mar; 8(11):17573-17585. PubMed ID: 28407679
[TBL] [Abstract][Full Text] [Related]
14. Association of ultrasonographic features with NGX6 expression and prognosis in invasive ductal breast carcinoma.
Xiao J; Zhou Y; Zhu W
Int J Clin Exp Pathol; 2015; 8(6):6458-65. PubMed ID: 26261522
[TBL] [Abstract][Full Text] [Related]
15. Eukaryotic expression, purification and structure/function analysis of native, recombinant CRISP3 from human and mouse.
Volpert M; Mangum JE; Jamsai D; D'Sylva R; O'Bryan MK; McIntyre P
Sci Rep; 2014 Feb; 4():4217. PubMed ID: 24573035
[TBL] [Abstract][Full Text] [Related]
16. Expression of Submaxillary Gland Androgen-regulated Protein 3A (SMR3A) in Adenoid Cystic Carcinoma of the Head and Neck.
Thierauf J; Veit JA; Grünow J; Döscher J; Weißinger S; Whiteside T; Beutner D; Quaas A; Plinkert P; Hoffmann TK; Hess J
Anticancer Res; 2016 Feb; 36(2):611-5. PubMed ID: 26851015
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer.
Yu BH; Li BZ; Zhou XY; Shi DR; Yang WT
Diagn Pathol; 2018 May; 13(1):36. PubMed ID: 29848352
[TBL] [Abstract][Full Text] [Related]
18. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
Hachim IY; Shams A; Lebrun JJ; Ali S
Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
[TBL] [Abstract][Full Text] [Related]
19. Cysteine-rich secretory protein 3 plays a role in prostate cancer cell invasion and affects expression of PSA and ANXA1.
Pathak BR; Breed AA; Apte S; Acharya K; Mahale SD
Mol Cell Biochem; 2016 Jan; 411(1-2):11-21. PubMed ID: 26369530
[TBL] [Abstract][Full Text] [Related]
20. Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment.
Sakurai M; Miki Y; Takagi K; Suzuki T; Ishida T; Ohuchi N; Sasano H
Breast Cancer Res; 2017 Jun; 19(1):70. PubMed ID: 28629450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
